<p>In-vitro Release profiles of EGCG from EGCG-LDH nanoparticle and physical mixture; at pH of a) 7.45 and b) 4.25.</p
<p>To examine the release kinetics of 5-FU nano-particles, multiple samples of the formulation were ...
<p>a) Phage release kinetics from Eudragit® S100 (ES100) and ES100/Alginate microparticles exposed t...
Biopolymeric microparticles have been widely used for long-term release formulations of short half-l...
<p>(A) Particle size graph showing the diameter of GC/5-FU (35.19±9.50 nm). (B) SEM image of GC/5-FU...
<p><i>In vitro</i> drug release profile at pH 7.4 showing the sustained release of ATV from the nano...
In studying in vitro drug release from nanoparticles (NPs) an important issue to consider is the met...
<p>Representative scanning electron photomicrographs of (<b>A</b>) blank and (<b>B</b>) 2% F1-V load...
<i>In vitro</i> drug release kinetics studies are routinely performed to examine the ability of new ...
As a growing number of nanotherapeutics enters the market, improved analytical techniques for measur...
<p>Release of doxorubicin from different types of PLGA nanoparticles stabilized by human serum album...
<p>Plots of kinetic equations of (A) first-orderkinetic model, (B) parabolic diffusion model,(C) Bha...
In recent years, the number of approved controlled release parenteral products such as biodegradable...
Nanoparticulate systems have emerged as prevalent drug delivery systems over the past few decades. T...
Progesterone containing nanoparticles constituted of tristearin or tristearin in association with ca...
To investigate the effect of different enteric polymers on the characteristics of pH-sensitive nanop...
<p>To examine the release kinetics of 5-FU nano-particles, multiple samples of the formulation were ...
<p>a) Phage release kinetics from Eudragit® S100 (ES100) and ES100/Alginate microparticles exposed t...
Biopolymeric microparticles have been widely used for long-term release formulations of short half-l...
<p>(A) Particle size graph showing the diameter of GC/5-FU (35.19±9.50 nm). (B) SEM image of GC/5-FU...
<p><i>In vitro</i> drug release profile at pH 7.4 showing the sustained release of ATV from the nano...
In studying in vitro drug release from nanoparticles (NPs) an important issue to consider is the met...
<p>Representative scanning electron photomicrographs of (<b>A</b>) blank and (<b>B</b>) 2% F1-V load...
<i>In vitro</i> drug release kinetics studies are routinely performed to examine the ability of new ...
As a growing number of nanotherapeutics enters the market, improved analytical techniques for measur...
<p>Release of doxorubicin from different types of PLGA nanoparticles stabilized by human serum album...
<p>Plots of kinetic equations of (A) first-orderkinetic model, (B) parabolic diffusion model,(C) Bha...
In recent years, the number of approved controlled release parenteral products such as biodegradable...
Nanoparticulate systems have emerged as prevalent drug delivery systems over the past few decades. T...
Progesterone containing nanoparticles constituted of tristearin or tristearin in association with ca...
To investigate the effect of different enteric polymers on the characteristics of pH-sensitive nanop...
<p>To examine the release kinetics of 5-FU nano-particles, multiple samples of the formulation were ...
<p>a) Phage release kinetics from Eudragit® S100 (ES100) and ES100/Alginate microparticles exposed t...
Biopolymeric microparticles have been widely used for long-term release formulations of short half-l...
DOI
Add to ORKG